RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • KCI등재
      • KCI등재후보

        골수 이식 환자에서 Azole계 항진균제와의 병용으로 인한 Cyclosporine의 혈중농도 변화

        정지혜,류성길,김재연,곽혜선,송영천 한국병원약사회 2010 病院藥師會誌 Vol.27 No.2

        Many studies of azole antifungal agents report that itraconazole is a more potent inhibitor of cytochrome P450 3A4(CYP3A4) than fluconazole. However, only a few reports from various clinical studies support it. This study was performed to study the effect of itraconazole and fluconazole on metabolism of cyclosporine(CsA), substrate of CYP3A4, by analyzing the blood concentrations of CsA. Total 141 patients who underwent bone marrow transplantation and were administered itraconazole or fluconazole combined with CsA from January 2008 to June 2009 in Asan Medical Center were enrolled. Data was collected retrospectively from electronic medical record(EMR). 56 patients received 389.29mg/day itraconazole(Sporanox solution, Janssen Korea) and 85 patients received 128.24mg/day fluconazole(Diflucan cpasule, Pfizer Korea). The dosage of CsA was not significantly different between itraconazole group(intravenous CsA 2.95±0.21mg/kg/day; oral CsA 3.59±1.51mg/kg/day) and fluconazole group(2.90±0.33mg/kg/day, p=0.351; 3.88±1.54mg/kg/day, p=0.466). Also, the period of combination was about 19 days in both groups. The blood concentrations of CsA were analyzed after combination with azoles. Data was collected three times; the first level(pre-steady-state level), the third level(steady-state level) and the highest level(peak TDM level) during the period of combination. In itraconazole group, blood concentrations of CsA were 101.60±59.91, 195.88±68.03 and 339.63±143.75ng/ml, respectively and peak TDM level was higher than the therapeutic range of CsA(100~300ng/ml). In fluconazole group, blood concentrations of CsA were 96.85±45.80(p=0.615), 173.74±60.75 (p=0.051) and 272.35±128.88ng/ml(p=0.006), respectively and peak TDM level was significantly lower than in itraconazole group. In conclusion, more careful monitoring of blood concentrations of CsA is recommended when CsA is combined with itraconazole than when combined with fluconazole.

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼